Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hannah Daniel

Having recently joined the team in 2022, Hannah Daniel is a consumer health reporter for Pharma Intelligence’s Health, Beauty, and Wellness publication.

Latest From Hannah Daniel

Urged By US FDA To Boost Infant Formula Supply, Additional Providers Still Must Wait For Approval

Patricia Hansen, CFSAN’s Office of Nutrition and Food Labeling deputy director and John Verbeten, deputy director for Import Operations Enforcement laid out the FDA's new enforcement guidance, and urged businesses with available formula to wait for approval before distributing formula in the US.

FDA Guidance Documents

House Appropriators Sound Off During FDA Hearing About Formula, More Consumer Health Issues

Before Agriculture/FDA subcommittee about FY2023 budget, Commissioner Robert Califf says FDA needs more resources to address unlisted fragrances in menstrual products and doesn’t have good regulatory options for hemp and kratom. His formula emergency comments leave members frustrated.

FDA Policy

Hemp Roundtable Says Safety Study Data Should Convince Congress On Lawful CBD Use

Study of 1,061 subjects showed oral CBD has robust safety profile, addressing FDA’s safety concerns and providing evidence to convince agency to take action on CBD regulation, say trade groups.

Legislation Cannabidiol CBD

USANA Lowers Guidance After 15% Q1 Sales Drop; Mannatech Reports Nearly $1M Undelivered Goods

Due to uncertainty in COVID-19 landscape in China, USANA adjusted its 2022 fiscal year guidance. Direct seller Mannatech decreased its number of fulfilled orders by 6% in the first quarter.

Companies Sales & Earnings

ChromaDex TV Ads Increase Sales, Customer Base

Tru Niagen sales made up more than 85% of first-quarter total, and TV ads launched in March drove a “dramatic increase” in customers, says CEO Robert Fried.

Sales & Earnings Launches

Familiar Leadership For J&J's Planned Consumer Spinoff

J&J's current consumer health division head, Thibaut Mongon, will be at the helm of its planned spinout of the business while Paul Ruh will move to the company was CFO. 

Executive Changes Leadership
See All
UsernamePublicRestriction

Register